Journal of Postgraduate Medicine
 Open access journal indexed with Index Medicus & ISI's SCI  
Users online: 3796  
Home | Subscribe | Feedback | Login 
About Latest Articles Back-Issues Articlesmenu-bullet Search Instructions Online Submission Subscribe Etcetera Contact
 ::   Next article
 ::   Previous article
 ::   Table of Contents

 ::   Similar in PUBMED
 ::  Search Pubmed for
 ::  Search in Google Scholar for
 ::   Citation Manager
 ::   Access Statistics
 ::   Reader Comments
 ::   Email Alert *
 ::   Add to My List *
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded0    
    Comments [Add]    

Recommend this journal


Year : 1977  |  Volume : 23  |  Issue : 4  |  Page : 181-185

Acceptability of thioamides II. Prothionamide

Department of Tuberculosis and chest diseases, L.L.R.M. Medical College, Meerut-250102., India

Correspondence Address:
D K Gupta
Department of Tuberculosis and chest diseases, L.L.R.M. Medical College, Meerut-250102.
Login to access the Email id

Source of Support: None, Conflict of Interest: None

PMID: 615265

Rights and PermissionsRights and Permissions

One hundred and fourteen patients with chronic advanced pulmonary tuberculosis were studied for 6 months to assess the acceptability of prothionamide at different dosage schedules and frequencies of intake of the drug. Gastrointestinal disturbances were most frequently encountered in patients of all the groups. Mild to severe toxic symptoms were recorded in 34.3 per cent, 44.7 per cent and 80 per cent patients receiving the drug in a daily dose of 500 mg, 750 mg and 1 gm respectively in groups A, B and C. At a dose of 500 mg per day, the incidence of toxicity was identical in the two sexes but beyond this dose it was slightly higher in females than in males. Age, chronicity o f illness and extent o f diseases did not have any influence on prothionamide acceptability. Toxic symptoms developed earlier in patients receiving higher doses of the drug. Prothionamide in a dose of 500 mg per day was very well tolerated by 65.7 per cent of patients and a considerable number of them tolerated a dose of 750 mg per day.

[FULL TEXT] [PDF Not available]*

Print this article     Email this article

Online since 12th February '04
2004 - Journal of Postgraduate Medicine
Official Publication of the Staff Society of the Seth GS Medical College and KEM Hospital, Mumbai, India
Published by Wolters Kluwer - Medknow